CIK 0001339970 · Non-accelerated filer<br>Smaller reporting company
aTYR PHARMA INC
Sign in to watch- Ticker
- ATYR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 203435077
- Phone
- 8587318389
- Business address
- 10240 SORRENTO VALLEY ROAD, SUITE 300, SAN DIEGO, CA, 92121
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-05-09 | Hatfield Jeffrey S. Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2017-05-09 | Goldberg Mark Alan Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2017-05-09 | Coughlin Timothy P Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2017-05-09 | CLARKE JOHN K Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2017-05-09 | AKKARAJU SRINIVAS Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2017-05-09 | BLAIR JAMES C Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2017-04-24 | MENDLEIN JOHN CEO and Director | Purchase | +124 | $3.00 | $372 | 327,647 |
| 2017-04-20 | MENDLEIN JOHN CEO and Director | Purchase | +1,552 | $3.00 | $5K | 327,523 |
| 2017-04-18 | MENDLEIN JOHN CEO and Director | Purchase | +1,000 | $3.00 | $3K | 325,971 |
| 2017-04-07 | Coughlin Timothy P Director | Grant or award · Stock Option (right to buy) | +32,000 | 32,000 | ||
| 2017-04-03 | Hatfield Jeffrey S. Director | Grant or award · Stock Option (right to buy) | +32,000 | 32,000 | ||
| 2017-02-07 | Shukla Sanjay Chief Medical Officer | Grant or award · Employee Stock Option (right to buy) | +65,000 | 65,000 | ||
| 2017-02-07 | Ravindran Sanuj K. Chief Business Officer | Grant or award · Employee Stock Option (right to buy) | +40,000 | 40,000 | ||
| 2017-02-07 | MENDLEIN JOHN CEO and Director | Grant or award · Employee Stock Option (right to buy) | +185,000 | 185,000 | ||
| 2017-02-07 | Matsuoka Grove See Remarks | Grant or award · Employee Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2017-02-07 | King David John See Remarks | Grant or award · Employee Stock Option (right to buy) | +65,000 | 65,000 | ||
| 2017-02-07 | Blake John T Senior Vice President, Finance | Grant or award · Employee Stock Option (right to buy) | +55,000 | 55,000 | ||
| 2017-02-07 | Blake John T Senior Vice President, Finance | Grant or award · Restricted Stock Unit | +10,000 | 10,000 | ||
| 2017-02-07 | Amanullah Ashraf Vice President, Manufacturing | Grant or award · Employee Stock Option (right to buy) | +35,000 | 35,000 | ||
| 2017-02-07 | Amanullah Ashraf Vice President, Manufacturing | Grant or award · Restricted Stock Unit | +10,000 | 10,000 |
Page 13 of 25 · 483 trades